DBS programming requirements and longevity
Objective: Determine need for programming for contemporary DBS systems, and the rate of explant, revision, or replacement. Background: DBS provides relief for motor symptoms of…Variability in the ideal target of GPi DBS for Parkinson’s disease requires advanced direct targeting for optimal results
Objective: Our findings have the potential to transform the clinical practice of surgeons who rely solely on indirect targeting, by raising awareness of the anatomic…Articulography reveals disturbed speech motor control in ET patients treated with VIM-DBS
Objective: We investigate the effect of VIM-DBS on speech production in patients with ET. Background: Dysarthria is a common side effect of VIM-DBS. In recent…Safety of deep brain stimulation for movement disorders: A single-centre long-term standardized recording and analysis
Objective: To analyze the long-term safety of Deep Brain Stimulation (DBS) procedures for patients with movement disorders. Background: DBS is currently indicated to treat several…Mild Parkinsonian signs and TIA/stroke
Objective: We aimed to determine if MPS increases TIA/stroke risk. Background: Mild Parkinsonian signs (MPS) are a syndrome of mild basal ganglia dysfunction characterized by…Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease
Objective: Aim of our study is to correlate the autonomic nervous system failure and circadian rhythm of arterial blood pressure in idiopathic REM behaviour disorders…Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic
Objective: To evaluate patient's awareness of reversible causes of worsening of Parkinson's disease (PD)1, their impact on symptoms and the role of abdominal x-ray (PFA)…Monitoring oxidative stress and progression to cell death: From secretome to blood diagnosis
Objective: To achieve a comprehensive method able to distinguish the secretome changes caused by oxidative stress regulation or induction of cell death, and thus be…Progressive supranuclear palsy as a manifestation of the second stage of CADASIL syndrome
Objective: To describe progressive supranuclear palsy (PSP) as a clinical manifestation of second stage CADASIL syndrome. Background: Recent data suggests that CADASIL syndrome in rare…MRI-supported diagnosis of multiple system atrophy: Implications for clinical trials
Objective: To assess whether MSA-specific MRI changes predict a more rapid clinical decline in a cohort of patients with a clinical diagnosis of MSA. Background:…
- « Previous Page
- 1
- …
- 51
- 52
- 53
- 54
- 55
- …
- 207
- Next Page »